Technical analysis of Corcept Therapeutics Incorporated (CORT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily.
Price Performance
| 1 month | +9.33% |
| 3 months | +31.30% |
| Year-to-date | +250.66% |
| 1 year | +35.82% |
| 3 years | +362.23% |
| 5 years | +515.07% |
52-Week Range
| 52-week High | $126.38 |
| 52-week Low | $28.66 |
| Avg Volume (90d) | 1.2M |
Technical Indicators
| SMA 50 | $113.53 |
| SMA 200 | $70.13 |
| Beta | 0.25 |
| 30-day Volatility (annualised) | 37.3% |
| Price vs SMA 50 | +7.5% |
| Price vs SMA 200 | +74.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-11 | $79.40 | |
| 2025-12 | $34.80 | -56.2% |
| 2026-01 | $39.87 | +14.6% |
| 2026-02 | $35.70 | -10.5% |
| 2026-03 | $40.31 | +12.9% |
| 2026-04 | $46.52 | +15.4% |
| 2026-05 | $69.49 | +49.4% |
| 2026-06 | $86.95 | +25.1% |
| 2026-07 | $114.49 | +31.7% |
| 2026-08 | $113.35 | -1.0% |
| 2026-09 | $115.23 | +1.7% |
| 2026-10 | $122.03 | +5.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-04 | $0.81 | $324M |
| 2026-07-29 | $0.02 | $221M |
| 2026-04-30 | $-0.11 | $185M |
| 2026-02-24 | $0.33 | $255M |
| 2025-11-04 | $0.18 | $255M |
| 2025-07-31 | $0.23 | $245M |
| 2025-05-05 | $0.17 | $217M |
Price
| Price | $122.03 |
| Market Cap | $13.2B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 223.52 |
| Price / Book | 17.35 |
| EV / EBITDA | 433.39 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 2.86 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 14.11 |